Access to New Pancreatic Cancer Drug Hindered by Insurance Delays
By Editor • September 8, 2026 • 2 min read
The FDA's approval of Rasonque for pancreatic cancer has not eased access for patients, who face daunting insurance hurdles.
Read moreBy Editor • September 8, 2026 • 2 min read
The FDA's approval of Rasonque for pancreatic cancer has not eased access for patients, who face daunting insurance hurdles.
Read moreBy Editor • September 3, 2026 • 2 min read
One year after the Morley Market fire, business owners continue to struggle with recovery and insurance issues.
Read moreBy Editor • September 2, 2026 • 1 min read
Planning is key for cancer patients wanting to travel, with insurance and medication management being top priorities.
Read moreBy Editor • August 26, 2026 • 1 min read
Rising costs force Australian show operators to reassess their future, with many making difficult choices amid soaring insurance and fuel prices.
Read moreBy Editor • August 26, 2026 • 2 min read
After a breast MRI was preapproved by her insurance, Stephanie Halver faced a shocking bill, highlighting gaps in coverage for preventive screenings.
Read moreBy Editor • August 13, 2026 • 1 min read
This week’s health news highlights concerns over disability protections and innovative responses to mental health crises.
Read more